Pear Therapeutics- Warrants (01/12/2026) Common Stock

Pear Therapeutics- Warrants (01/12/2026) posts a common stock of $14K as of December 2022. That compares with $14K in the prior-year period — up 0.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Pear Therapeutics- Warrants (01/12/2026)'s common stock was $14K. The latest reading is $14K — essentially flat versus a year earlier (period ending December 2022). Use the history and growth charts on this page for a longer lookback.

Common Stock is one piece of Pear Therapeutics- Warrants (01/12/2026)'s financial statement story. At $14K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PEARW's common stock usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Pear Therapeutics- Warrants (01/12/2026)'s other metric pages and overview cover the third.